Background-Short-term and tonic regulation of arterial blood pressure (BP) differ in premenopausal women and men of similar age. The autonomic nervous system (ANS) plays a critical role in BP regulation. Methods and Results-To test the hypothesis that women have lower tonic ANS support of BP (reduction in intra-arterial BP during acute ganglionic blockade [GB] with intravenous trimethaphan) and less effective baroreflex buffering (BRB) of BP (potentiation of the systolic BP [SBP] response to bolus phenylephrine during versus before GB) than men, 51 healthy adults, 22 premenopausal women (aged 28Ϯ1 years, meanϮSE) and 29 men (aged 27Ϯ1 years), were studied. Women had lower baseline SBP and plasma catecholamine concentrations than men (PϽ0.05). Tonic ANS support of BP was Ϸ50% to 65% lower in the women (PϽ0.001). The reductions in BP during GB were related to baseline plasma catecholamine concentrations (rϭϪ0.31 to Ϫ0.41, PϽ0.05). Acute BRB of BP was 47% smaller in the women (3.3Ϯ0.5 versus 6.3Ϯ0.9, Pϭ0.006) and was related to the SBP responses to phenylephrine before GB (R 2 ϭ0.71, PϽ0.0001). Systemic ␣ 1 -adrenergic vascular responsiveness (SBP response to bolus phenylephrine during GB) was not different (women 21.5Ϯ2 mm Hg versus men 18.6Ϯ2 mm Hg, Pϭ0.3). Conclusions-Premenopausal women have lower tonic sympathoadrenal activity-related ANS support of BP and less effective BRB of BP than men of similar age. The lower tonic ANS support of BP could contribute to the lower chronic BP levels of premenopausal women, whereas attenuated BRB of BP may help explain less effective BP regulation in women in response to vasoactive drugs and acute stress. (Circulation. 2005;111:494-498.) 
S hort-term and tonic regulation of arterial blood pressure (BP) differs between premenopausal women and men of similar age. [1] [2] [3] [4] The autonomic nervous system (ANS) plays a critical role in BP regulation. Surprisingly, however, little or no direct evidence exists regarding possible gender-related differences in ANS control of BP in humans.
With respect to tonic BP control, premenopausal women have lower resting BP, particularly systolic BP (SBP), than men. 1, 5, 6 The ANS provides tonic support for resting BP, and we recently established that basal sympathetic nervous system activity is a key physiological determinant of the amount of tonic BP support provided by the ANS. 7 Because premenopausal women tend to have lower resting sympathetic activity than men, [2] [3] [4] 8 we hypothesized that women have lower tonic ANS support of BP than men.
With regard to short-term BP regulation, baroreflexes are an important mechanism by which the central nervous system controls BP in response to acute challenges im-posed by stress, vasoactive drugs, and other stimuli. The ability of baroreflexes to "buffer" acute changes in BP under such conditions (ie, baroreflex buffering [BRB]) is reduced in certain physiological 9 and disease 10 states associated with impaired short-term BP regulation and/or altered responsiveness to vasoactive medications. In light of previous reports of less effective short-term regulation of BP in women than in men, 1, 2, 6, [11] [12] [13] [14] we also hypothesized that premenopausal women have lower BRB of BP than men of similar age.
To test these hypotheses, we performed direct measurements of tonic ANS support of BP and BRB of BP in groups of healthy premenopausal women and age-matched men. We also measured resting sympathoadrenal activity and systemic ␣ 1 -adrenergic vascular responsiveness, 2 key determinants of these expressions of ANS control of BP, 7, 9, 10, 15, 16 to determine their potential mechanistic roles in any gender-related differences observed.
Methods

Subjects
Fifty-one young adults, 22 premenopausal women (aged 28Ϯ1 years) and 29 men (aged 27Ϯ1 years), were studied. Men and women were recruited from the community with flyers and newspaper advertisements. More than 80% of the subjects in each group were white. Subjects were normotensive (BP Ͻ140/90 mm Hg) nonsmokers who were not taking any medications. None of the women were using hormonal contraception. All subjects were considered to be healthy on the basis of medical history, physical examination, urinalysis, blood chemistries, and resting ECGs. The nature, benefits, and risks of the study were explained to the volunteers, and their written informed consent was obtained before the study. Data collection on all subjects was performed at the General Clinical Research Centers of the University of Colorado's Health Sciences Center and Boulder campuses and Vanderbilt University Medical School. Procedures were approved by the institutional review boards of these institutions and were in accordance with their respective guidelines.
Autonomic-Cardiovascular Function
Subjects were studied during supine rest according to procedures previously described. 7, 9 In general, BP (mm Hg) was continuously monitored by a pressure transducer (radial or brachial artery catheter). Heart rate was measured via ECG. Plasma samples were analyzed for catecholamine 17 concentrations. In a subgroup of 8 premenopausal women and 8 men (both groups aged 26Ϯ1 years), we measured plasma vasopressin 18 concentrations before and during ganglionic blockade (GB).
ANS support of BP was determined as the reduction in BP from baseline during GB achieved by blockade of N N -cholinergic receptors via continuous intravenous infusion of trimethaphan (on average 6 to 7 mg/min). 7 The trimethaphan dose was not based on body weight; instead, trimethaphan infusion began at 2 mg/min and was increased incrementally until complete GB was documented. This effective blocking dose was maintained throughout the experimental session. Complete cardiovascular-autonomic blockade was documented by an absence of change in heart rate (Ͻ5 bpm) in response to the acute increase in BP (Ն15 mm Hg) produced by bolus administration of phenylephrine (25, 50, and/or 100 g). BRB was measured in a subgroup of 14 women and 14 men (aged 26Ϯ1 and 27Ϯ1 years, respectively) as the potentiation of the SBP response to a standard 25-g bolus dose of phenylephrine during GB compared with before GB. 9, 19 The increase in SBP in response to phenylephrine during GB was used to determine systemic ␣ 1 -adrenergic vascular responsiveness. 9, 20 Cardiovagal baroflex sensitivity (BRS) was determined at baseline (ie, before trimethaphan) in a subgroup of 12 women and 12 men (27Ϯ1 and 26Ϯ1 years, respectively) by administering incremental bolus doses of phenylephrine (25, 50 100, 200 g) at 3-minute intervals and regressing R-R intervals against SBP. 21, 22 
Data Analysis
Statistical analyses were performed with the SPSS (version 11.0) statistical package. Gender comparisons were made with t tests for independent samples. Responses to trimethaphan were analyzed with repeated-measures ANOVA with condition (baseline versus GB) as the within-subject factor and gender as the between-subject factor. The gender-by-condition interaction was of particular interest. ANCOVA was used to control for baseline differences in SBP between the 2 groups. Curve estimation analysis was used to fit the curvilinear relation between BRB and the increase in SBP in response to phenylephrine at baseline. Visual inspection of the fit of the model, examination of the R 2 and associated probability values, and examination of the distribution, normality, and autocorrelation of the residuals were the criteria used to choose the most appropriate model. Alpha was set at 0.05. All data are reported as meanϮSE.
Results
The Table shows selected characteristics of the 2 subject groups. Weight, body mass index, SBP, plasma norepinephrine and epinephrine concentrations, and cardiovagal BRS (16Ϯ1 versus 24Ϯ3 ms/mm Hg) were lower in the women compared with the men (PϽ0.05), whereas mean and diastolic BP and heart rate were not different in the 2 groups (PϾ0.05).
Tonic ANS Support of BP
SBP and mean and diastolic BP decreased in both groups in response to GB (all PϽ0.001 versus baseline; Figure 1) ; however, the reductions were Ϸ50% to 65% smaller in the women (PϽ0.001). A smaller reduction in BP during GB was related to lower baseline plasma catecholamine concentrations (rϭϪ0.31 to Ϫ0.41, PϽ0.05 to 0.01). A smaller reduction in SBP during GB also was related to a lower baseline SBP (rϭϪ0.45, Pϭ0.001); however, the group differences were still highly significant (Pϭ0.001) after covarying for baseline SBP.
Heart rate increased (PϽ0.0001 versus baseline) similarly (25Ϯ2 versus 24Ϯ2 bpm, Pϭ0.8) in the 2 groups in response to GB. Plasma vasopressin concentrations increased (PϽ0.05) in response to GB in both groups, but the increases were smaller in the women (0.6Ϯ0.1 ng/L at baseline to 8.0Ϯ4.3 ng/L during GB versus 0.7Ϯ0.1 to 54.2Ϯ23.7 ng/L, PϽ0.05).
Baroreflex Buffering
At baseline (before GB), the increase in SBP in response to phenylephrine was 105% greater in the women (7.6Ϯ0.9 versus 3.7Ϯ0.5 mm Hg, Pϭ0.001; Figure 2 ), whereas the increases in SBP in response to phenylephrine during GB were not significantly different in the 2 groups (21.5Ϯ2 mm Hg in women versus 18.6Ϯ2 mm Hg in men, Pϭ0.3; Figure 2 ). As a result, potentiation of the SBP response to phenylephrine during GB (ie, BRB) was 47% smaller in the women (3.3Ϯ0.5-fold versus 6.3Ϯ0.9-fold, PϽ0.001; Figure 2 ). BRB was strongly inversely and curvilinearly related to the increase in SBP in response to phenylephrine at baseline (R 2 ϭ0.71, PϽ0.0001; BRBϭ14(⌬SBP in response to phenylephrine bolus) Ϫ0.8 ; Figure 3 ). BRB was not related to baseline SBP, BRS, or any other subject characteristic (all PϾ0.05). 
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Discussion
The major novel findings of this study include the following. First, healthy premenopausal women have lower tonic ANS support of BP than healthy men of similar age. The lower tonic ANS support of BP in women is related in part to their lower basal sympathoadrenal system activity. Second, premenopausal women have less effective BRB of BP than young men. Third, systemic ␣ 1 -adrenergic vascular responsiveness is not different in healthy premenopausal adult women and men of the same age. These findings provide the first direct experimental evidence in humans that these fundamental properties of short-term and tonic ANS control of BP differ between women and men.
Tonic ANS Support of BP
We recently established that basal sympathetic nervous system activity, as reflected in part by plasma norepinephrine concentrations, and systemic ␣ 1 -adrenergic vascular responsiveness are the 2 primary physiological correlates of tonic ANS support of BP in healthy men. 7 In the present study, the reductions in BP during GB were significantly related to basal plasma catecholamine concentrations, which supports the idea that the lower resting sympathoadrenal activity in the women contributed to their lower tonic ANS support of BP. The underlying mechanisms are uncertain, but presumably smaller tonic sympathoadrenal stimulation of cardiac output and/or systemic vascular resistance is involved. In contrast, the increases in SBP in response to phenylephrine during GB were not different in men and women in the present study, which indicates that differences in systemic ␣ 1 -adrenergic vascular responsiveness did not contribute to gender-related differences in tonic ANS support of BP. The present results represent the first direct measurements of systemic ␣-adrenergic vascular responsiveness in men and women and correct previous findings of gender-related differences in responsiveness based on BP responses to systemic infusions of ␣-adrenergic agonists with intact baroreflexes. 13 We have shown that circulating levels of vasopressin increase in response to the decrease in BP produced by GB. 7, 15, 19 The vasoconstrictor effects of vasopressin can counteract the reductions in BP during GB and thus lead to an underestimation of tonic ANS support of BP. In the present study, however, the vasopressin response to GB-mediated hypotension was modest in the women but much greater in the men. Thus, if anything, this difference in the vasopressin counterregulatory responses to GB would have caused an underestimation of the true gender-related differences in tonic ANS support of BP in the present study.
Baroreflex Buffering
Because the magnitude of the BP response to vasoactive drugs is the net effect of vascular sensitivity to the drug (ϩ) and the counterregulatory actions of the baroreflexes (Ϫ), the potentiation of the BP response to phenylephrine during GB (absence of baroreflexes) compared with baseline (intact baroreflexes) provides a measure of the in vivo capacity of the baroreflexes to buffer acute changes in BP. 10, 16 Recently, we have used this model to examine BRB in patients with ANS-cardiovascular disorders, 10, 16 as well as healthy young and older men. 9, 20 The results of these studies indicate that differences in BRB among groups or individuals are not consistently related to resting BP, heart rate, or cardiovagal BRS, nor was BRB by the present phenylephrine bolus technique related to basal plasma catecholamine concentrations. 9, 10 Rather, of relevance to the present study, BRB was positively related to systemic ␣ 1 -adrenergic vascular responsiveness among healthy men. 9 The physiological basis for this latter relation is that the neurovascular coupling between sympathetic nerve discharge, norepinephrine release, and the responsiveness of the vascular smooth muscle to the consequent ␣-adrenergic stimulation is the final step in the sympathetic-vasoconstrictor arm of the baroreflexes.
In the present study, BRB was not significantly related to baseline cardiovascular function, plasma catecholamine concentrations, or any other subject characteristic, which suggests that neither differences in resting BP, tonic sympathoadrenal activity, nor any other baseline factor were mechanistically involved in the gender-related differences in BRB. Moreover, systemic ␣ 1 -adrenergic vascular responsiveness was not different in the men and women and did not correlate with BRB in the pooled group of subjects. As reported previously, 1,23-25 baseline cardiovagal BRS was lower in the women. In agreement with our previous observations, 9, 10 however, cardiovagal BRS was not consistently related to BRB, which reinforces the important point that the 2 measures represent different properties of the baroreflexes. 9, 10 The differences in BRB between women and men in the present study, therefore, are mediated by 1 or more currently undetermined differences in the afferent, central regulatory, or ANS efferent elements of the baroreflexes.
In the present investigation, we found that the SBP response to phenylephrine at baseline was greater in women than in men, in agreement with an earlier report. 13 We previously demonstrated that BRB is strongly and inversely related to this pressor response to phenylephrine in healthy men and patients with ANS-cardiovascular disorders. 9, 10 In the present study, we found a similarly strong, inverse curvilinear relation among the pooled male and female subjects ( Figure 3 ). Given that systemic ␣ 1 -adrenergic vascular responsiveness was not different in the men and women, this relation suggests that the greater SBP response to phenylephrine at baseline in the women reflects a reduced capacity for BRB of BP. Indeed, as emphasized previously, 9, 10 the consistency of this relation indicates that the baseline SBP response to a standard 25-g bolus of phenylephrine can be used to identify impaired BRB among both healthy adults and patients with chronic diseases that adversely affect baroreflex function. The flat portion of the curve indicates that individuals demonstrating SBP responses to phenylephrine of more than Ϸ5 mm Hg at baseline (ie, with intact baroreflexes) have similarly low BRB capacity.
Study Limitations
In the present investigation, we only used a vasoactive drug that produced increases in BP (ie, phenylephrine) to determine BRB, rather than in combination with a drug that produced reductions in BP (eg, nitroprusside). This was because systemic administration of vasodilators such as nitroprusside during GB in normotensive adults can cause BP to fall to levels associated with inappropriately high risks, particularly for healthy volunteers. However, Jordan and colleagues 10 have demonstrated that the same group differences in BRB are revealed when phenylephrine or nitroprusside is used. In addition, the trimethaphan and phenylephrine doses used in the present study were not based on body weight. Given the differences in body weight in men and women in the present study, one might question whether this factor influenced our results. However, although the amount of trimethaphan administered was not weight-based, the dose was adjusted until complete GB was produced and confirmed. Moreover, body weight did not influence the BP responses to the standard bolus of phenylephrine administered, because the effect of gender was unaffected after statistically covarying for body weight. Finally, measurements in the women were not obtained during a standardized phase of the menstrual cycle. Measurement of some ANS-cardiovascular functions differ between phases of the menstrual cycle. 26 -28 It is possible that measures of ANS function in the present study may have been different in the women in other phases of their menstrual cycle; however, the lack of standardization in the present study would have introduced more variability into the data. We were able to demonstrate highly significant group differences in the key outcomes despite this factor.
Clinical Implications
Premenopausal women typically have lower resting BP, particularly SBP, than young men, 1, 5, 6 but the underlying mechanisms are poorly understood. The results of the present study indicate that less tonic ANS support may be 1 mechanism that contributes to the lower resting BP in young women. The fact that the lower ANS support of SBP in the women was related to their lower resting SBP is consistent with this possibility. Moreover, women often demonstrate less effective BP regulation than men during acute challenges (eg, orthostatic stress) and in response to vasoactive drugs. 1, 2, 4, 6, [11] [12] [13] [14] The responsible mechanisms have not been identified, but the results of the present study indicate that a reduced ability for BRB of acute changes in BP may play a central role in the less effective short-term BP control observed in women.
We also wish to emphasize the magnitude of the genderrelated differences in tonic ANS support of BP and BRB of BP observed in the present study. The gender-group differences were generally as great or greater than those observed between young and older healthy men 7, 9 and between healthy controls and patients with orthostatic intolerance. 10 Indeed, the gender-related difference in BRB in the present study was almost as great as the difference recently found between healthy adults and patients with long-standing essential hypertension. 10, 16 Thus, consistent with previous reports of gender-related differences in other ANS-cardiovascular functions, [1] [2] [3] [4] 8, [23] [24] [25] the present findings indicate that subject gender is a major source of interindividual variability in tonic ANS support of BP and BRB of BP in healthy adult humans.
Conclusions
Premenopausal women have lower tonic sympathoadrenal activity-related ANS support of BP and less effective BRB of BP than men of similar ages. These findings may provide novel insight into the physiological mechanisms underlying gender-related differences in short-term and tonic regulation of BP in humans.
